Printer Friendly

Imaging Diagnostic Systems' 'Painless Mammogram' eliminates drawbacks of conventional screening.

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Dec. 14, 1995--The Chief Executive Officer, President and General Counsel of Imaging Diagnostic Systems Inc. (OTC EBB:IMDS) met with the FDA on Dec. 12 and submitted a pre IDE application and expects to submit in 7 to 10 days a formal Investigational Device exemption application.

Imaging Diagnostic Systems will be the modality of choice with its revolutionary CT Laser Mammography. The CTLM(tm) uses high-speed laser technology with sophisticated algorithms to produce images while eliminating the drawbacks of radiation and discomfort from breast compression for the life-saving diagnostic procedure.

With comparative studies commencing, IDS is preparing to meet the demands of the domestic and international market for its new device, which generated global interest at the recent RSNA conference, including several prestigious medical institutions in the United States.

The CTLM(tm) was recently featured on the Donahue Show and on ABC News, CBS National News, WPIX-TV and articles in The Wall Street Journal and Associated Press. IDS has also received industry accolades for their advancement in laser technology for improved Medical Optical Imaging in numerous trade publications including, The Gray Sheet, Diagnostic Imaging and Applied Radiology. The CTLM(tm) is being referred to by the consumer as the "Painless Mammogram."

"Women have been waiting a long time for something less painful and more dignified to come along, and with CTLM(tm) we will reach a large sector of the female population that refuses to be subjected to traditional methods of mammography," said Richard Grable, CEO and inventor of the CTLM. "We know we have an exceptional product that is years ahead of even the largest companies," he said.

"Until we have the green light from the FDA, we will pursue clinical sites in the U.S. and sales in the foreign markets," said Linda Grable, president of IDS. One of Europe's largest distributors of medical equipment, Medical Development East, is negotiating delivery of the CTLM(tm) for placement at the Moscow Research in Russia in July 1996. Current sales to the Asian market for delivery in 1996 is approximately $1.5 million.

Imaging Diagnostic Systems Inc. has a proprietary state-of-the-art breast imaging device, CTLM(tm) which requires no breast compression, uses no x-rays -- producing detailed cross-sectional images of the tissue.

CONTACT: International Buying Power Corp., Boca Raton, Fla.

407/392-3404, fax 407/392-4775
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion




Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 14, 1995
Previous Article:Trailblazing student investment fund garners additional $875,000 in investment capital in second offering.
Next Article:Investment brokers see weakening stock market in 1996, say clients will pursue safety; Majority Foresee Higher Demand for Insured Municipal Bonds;...

Related Articles
What's in a Name Change?
Coding for the female patient in 2002. (Featured Cme topic: Female Patient).
Racial and age-related disparities in obtaining screening mammography: results of a statewide database.
MagView Systems partners with R2 Technology to integrate software on R2's computer aided detection--CAD--system.
3-D vision: new technique could improve breast cancer screening, diagnosis.
Focus is breast cancer awareness.

Terms of use | Copyright © 2015 Farlex, Inc. | Feedback | For webmasters